Cargando…

Rare leptin in non-alcoholic fatty liver cirrhosis: A case report

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD)-related cirrhosis is mainly caused by NAFLD by causing inflammation which leads to fibrosis. The role of leptin in NAFLD-related cirrhosis has been rarely reported. CASE SUMMARY: This study presents the case of a 65-year-old male patient who was...

Descripción completa

Detalles Bibliográficos
Autores principales: Nong, Yao-Bin, Huang, Hong-Na, Huang, Jing-Jing, Du, Yuan-Qin, Song, Wen-Xuan, Mao, De-Wen, Zhong, Yue-Xue, Zhu, Rong-Huo, Xiao, Xi-Yu, Zhong, Rui-Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561580/
https://www.ncbi.nlm.nih.gov/pubmed/36246792
http://dx.doi.org/10.12998/wjcc.v10.i28.10293
_version_ 1784807977261203456
author Nong, Yao-Bin
Huang, Hong-Na
Huang, Jing-Jing
Du, Yuan-Qin
Song, Wen-Xuan
Mao, De-Wen
Zhong, Yue-Xue
Zhu, Rong-Huo
Xiao, Xi-Yu
Zhong, Rui-Xi
author_facet Nong, Yao-Bin
Huang, Hong-Na
Huang, Jing-Jing
Du, Yuan-Qin
Song, Wen-Xuan
Mao, De-Wen
Zhong, Yue-Xue
Zhu, Rong-Huo
Xiao, Xi-Yu
Zhong, Rui-Xi
author_sort Nong, Yao-Bin
collection PubMed
description BACKGROUND: Non-alcoholic fatty liver disease (NAFLD)-related cirrhosis is mainly caused by NAFLD by causing inflammation which leads to fibrosis. The role of leptin in NAFLD-related cirrhosis has been rarely reported. CASE SUMMARY: This study presents the case of a 65-year-old male patient who was referred to The First Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi, China, for diagnosis and treatment for liver cirrhosis. Initially, the cause of liver cirrhosis was unknown. After radiology, laboratory examination, pathological results and analysis of the patient’s signs and symptoms, the case was finally diagnosed with final NAFLD-related cirrhosis. Although this study reports a single case, the findings might expand the understanding of leptin’s role in NAFLD-related cirrhosis and might provide a basis for the clinical diagnostic criteria, pathological features and treatment of NAFLD-related cirrhosis. CONCLUSION: Although the occurrence of marasmus NAFLD-related cirrhosis is rare, it needs to be distinguished from other liver diseases, including viral hepatitis, drug-induced liver disease, Wilson's disease and autoimmune liver disease. Aggressive treatment is needed to prevent the progression of NAFLD-related cirrhosis.
format Online
Article
Text
id pubmed-9561580
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-95615802022-10-15 Rare leptin in non-alcoholic fatty liver cirrhosis: A case report Nong, Yao-Bin Huang, Hong-Na Huang, Jing-Jing Du, Yuan-Qin Song, Wen-Xuan Mao, De-Wen Zhong, Yue-Xue Zhu, Rong-Huo Xiao, Xi-Yu Zhong, Rui-Xi World J Clin Cases Case Report BACKGROUND: Non-alcoholic fatty liver disease (NAFLD)-related cirrhosis is mainly caused by NAFLD by causing inflammation which leads to fibrosis. The role of leptin in NAFLD-related cirrhosis has been rarely reported. CASE SUMMARY: This study presents the case of a 65-year-old male patient who was referred to The First Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi, China, for diagnosis and treatment for liver cirrhosis. Initially, the cause of liver cirrhosis was unknown. After radiology, laboratory examination, pathological results and analysis of the patient’s signs and symptoms, the case was finally diagnosed with final NAFLD-related cirrhosis. Although this study reports a single case, the findings might expand the understanding of leptin’s role in NAFLD-related cirrhosis and might provide a basis for the clinical diagnostic criteria, pathological features and treatment of NAFLD-related cirrhosis. CONCLUSION: Although the occurrence of marasmus NAFLD-related cirrhosis is rare, it needs to be distinguished from other liver diseases, including viral hepatitis, drug-induced liver disease, Wilson's disease and autoimmune liver disease. Aggressive treatment is needed to prevent the progression of NAFLD-related cirrhosis. Baishideng Publishing Group Inc 2022-10-06 2022-10-06 /pmc/articles/PMC9561580/ /pubmed/36246792 http://dx.doi.org/10.12998/wjcc.v10.i28.10293 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Case Report
Nong, Yao-Bin
Huang, Hong-Na
Huang, Jing-Jing
Du, Yuan-Qin
Song, Wen-Xuan
Mao, De-Wen
Zhong, Yue-Xue
Zhu, Rong-Huo
Xiao, Xi-Yu
Zhong, Rui-Xi
Rare leptin in non-alcoholic fatty liver cirrhosis: A case report
title Rare leptin in non-alcoholic fatty liver cirrhosis: A case report
title_full Rare leptin in non-alcoholic fatty liver cirrhosis: A case report
title_fullStr Rare leptin in non-alcoholic fatty liver cirrhosis: A case report
title_full_unstemmed Rare leptin in non-alcoholic fatty liver cirrhosis: A case report
title_short Rare leptin in non-alcoholic fatty liver cirrhosis: A case report
title_sort rare leptin in non-alcoholic fatty liver cirrhosis: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561580/
https://www.ncbi.nlm.nih.gov/pubmed/36246792
http://dx.doi.org/10.12998/wjcc.v10.i28.10293
work_keys_str_mv AT nongyaobin rareleptininnonalcoholicfattylivercirrhosisacasereport
AT huanghongna rareleptininnonalcoholicfattylivercirrhosisacasereport
AT huangjingjing rareleptininnonalcoholicfattylivercirrhosisacasereport
AT duyuanqin rareleptininnonalcoholicfattylivercirrhosisacasereport
AT songwenxuan rareleptininnonalcoholicfattylivercirrhosisacasereport
AT maodewen rareleptininnonalcoholicfattylivercirrhosisacasereport
AT zhongyuexue rareleptininnonalcoholicfattylivercirrhosisacasereport
AT zhuronghuo rareleptininnonalcoholicfattylivercirrhosisacasereport
AT xiaoxiyu rareleptininnonalcoholicfattylivercirrhosisacasereport
AT zhongruixi rareleptininnonalcoholicfattylivercirrhosisacasereport